Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Nautilus Biotechnology Inc.
NAUT | US
2.77
USD-0.18
-6.10%
NAUT | US
About Nautilus Biotechnology Inc.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
2.77
Open
2.92
High
2.94
Low
2.75
Nautilus Biotechnology Inc. a development stage life sciences company engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform a proteomics platform that includes end-to-end solution comprised of instruments consumables and software analysis. The company was incorporated in 2016 and is headquartered in Seattle Washington.
View LessNAUT | US
Risk
70.5
Sharpe
-0.02
Luna's Score
46/100
Recommendation
Hold
Luna says (NAUT | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
57.5%1 month
70.5%3 months
60.7%6 months
59.3%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.53
Debt to equity
0.14
Debt to assets
0.12
Ent. to EBITDA
-2.00
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-79.42M
MarketCap
347.39M
MarketCap(USD)
347.39M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-26.53
Short ratio
13.56
Short perc.
2.90
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.41
Range1M
0.47
Range3M
0.89
Volumes: Market Activity
Rel. volume
0.81
Price X volume
137.72K
